Stockreport

Immunic to Participate in Investor and Scientific Conferences in March [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in March: March [Read more]